BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 3082277)

  • 1. Decomposition of mitomycin and anthracycline cytostatics in cell culture media.
    Beijnen JH; Van der Nat JM; Labadie RP; Underberg WJ
    Anticancer Res; 1986; 6(1):39-43. PubMed ID: 3082277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I and II agents in cancer therapy: I. Anthracyclines and related compounds.
    Wadler S; Fuks JZ; Wiernik PH
    J Clin Pharmacol; 1986; 26(7):491-509. PubMed ID: 2944917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetics of new anthracyclines].
    Robert J
    Bull Cancer; 1988; 75(2):167-74. PubMed ID: 3282579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives.
    Young CW; Raymond V
    Cancer Treat Rep; 1986 Jan; 70(1):51-63. PubMed ID: 2935251
    [No Abstract]   [Full Text] [Related]  

  • 5. Different cytotoxicity and metabolism of doxorubicin, daunorubicin, epirubicin, esorubicin and idarubicin in cultured human and rat hepatocytes.
    Le Bot MA; Bégué JM; Kernaleguen D; Robert J; Ratanasavanh D; Airiau J; Riché C; Guillouzo A
    Biochem Pharmacol; 1988 Oct; 37(20):3877-87. PubMed ID: 3190734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of antitumor anthracyclines and new developments in their application: Cain memorial award lecture.
    Arcamone F
    Cancer Res; 1985 Dec; 45(12 Pt 1):5995-9. PubMed ID: 3864526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of anthracycline--DNA complexes by circular dichroism.
    Rizzo V; Penco S; Menozzi M; Geroni C; Vigevani A; Arcamone F
    Anticancer Drug Des; 1988 Aug; 3(2):103-15. PubMed ID: 3165639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular pharmacokinetics of aclacinomycin A in cultured L1210 cells. Comparison with daunorubicin and doxorubicin.
    Zenebergh A; Baurain R; Trouet A
    Cancer Chemother Pharmacol; 1982; 8(2):243-9. PubMed ID: 6955072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiotoxicity and comparative pharmacokinetics of six anthracyclines in the rabbit.
    Jaenke RS; Deprez-DeCampeneere D; Trouet A
    Cancer Res; 1980 Oct; 40(10):3530-6. PubMed ID: 6934026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro formation of a toxic aglycone metabolite of 4-demethoxydaunorubicin in conditions that parallel the stomach.
    Cummings J; Milroy R
    Anticancer Res; 1986; 6(5):1177-9. PubMed ID: 3467647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anthracycline analogs: the past, present, and future.
    Weiss RB; Sarosy G; Clagett-Carr K; Russo M; Leyland-Jones B
    Cancer Chemother Pharmacol; 1986; 18(3):185-97. PubMed ID: 2948729
    [No Abstract]   [Full Text] [Related]  

  • 12. Markedly reduced levels of anthracycline-induced DNA strand breaks in resistant P388 leukemia cells and isolated nuclei.
    Capranico G; Riva A; Tinelli S; Dasdia T; Zunino F
    Cancer Res; 1987 Jul; 47(14):3752-6. PubMed ID: 3474061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of new anthracycline antibiotics 1-hydroxy-oxaunomycin and 6-deoxyoxaunomycin by limited biosynthetic conversion using a daunorubicin-negative mutant.
    Yoshimoto A; Johdo O; Tone H; Okamoto R; Naganawa H; Sawa T; Takeuchi T
    J Antibiot (Tokyo); 1992 Oct; 45(10):1609-17. PubMed ID: 1473988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adriamycin and related anthracycline antibiotics.
    Brown JR
    Prog Med Chem; 1978; 15():125-64. PubMed ID: 400611
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy of acute leukemia: contribution of the new anthracyclinic drugs].
    Lambertenghi-Deliliers G; Colajori E; Annaloro C; Polli EE
    Recenti Prog Med; 1985; 76(7-8):392-7. PubMed ID: 3906794
    [No Abstract]   [Full Text] [Related]  

  • 16. Anthracycline antibiotic pharmacology and metabolism.
    Bachur NR
    Cancer Treat Rep; 1979 May; 63(5):817-20. PubMed ID: 455323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anthracycline resistance mediated by reductive metabolism in cancer cells: the role of aldo-keto reductase 1C3.
    Hofman J; Malcekova B; Skarka A; Novotna E; Wsol V
    Toxicol Appl Pharmacol; 2014 Aug; 278(3):238-48. PubMed ID: 24832494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of RNA synthesis in vitro and cell growth by anthracycline antibiotics.
    Studzian K; Wasowska M; Piestrzeniewicz MK; Wilmańska D; Szmigiero L; Oszczapowicz I; Gniazdowski M
    Neoplasma; 2001; 48(5):412-8. PubMed ID: 11845988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative activity of anthracycline 13-dihydrometabolites against rat glioblastoma cells in culture.
    Schott B; Robert J
    Biochem Pharmacol; 1989 Nov; 38(22):4069-74. PubMed ID: 2597184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adriamycin and its analogs].
    Arcamone F
    Tumori; 1984 Apr; 70(2):113-9. PubMed ID: 6587651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.